Business Segments · Total Capital Expenditures
Medical — Total Capital Expenditures
Becton, Dickinson and Company Medical — Total Capital Expenditures remained flat by 0.0% to $150.50M in Q3 2022 compared to the prior quarter. Year-over-year, this metric declined by 22.5%, from $194.25M to $150.50M.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2018
Last reportedQ1 2026
How to read this metric
An increase suggests aggressive investment in capacity or automation, while a decrease may indicate a shift toward asset-light operations or the completion of major capital projects.
Detailed definition
This metric represents the total cash outflows used by the Medical segment to acquire, upgrade, and maintain physical as...
Peer comparison
Comparable to 'Capital Expenditures' or 'Purchases of Property, Plant, and Equipment' reported by other medical device manufacturers.
Metric ID:
bdx_segment_medical_total_capital_expendituresHistorical Data
2 years
| FY'21 | FY'22 | |
|---|---|---|
| Value | $777.00M | $602.00M |
| YoY Change | — | -22.5% |
Range$602.00M – $777.00M
Avg YoY Growth-22.5%
Median YoY Growth-22.5%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Becton, Dickinson and Company's medical — total capital expenditures?
- Becton, Dickinson and Company (BDX) reported medical — total capital expenditures of $150.50M in Q3 2022.
- How has Becton, Dickinson and Company's medical — total capital expenditures changed year-over-year?
- Becton, Dickinson and Company's medical — total capital expenditures decreased by 22.5% year-over-year, from $194.25M to $150.50M.
- What does medical — total capital expenditures mean?
- The total amount of money spent by the Medical segment on long-term physical assets and infrastructure.